Ghatnekar, Ola, Frida Hjalte, and Matthew Taylor. 2010. “Cost-Effectiveness of Dasatinib Versus High-Dose Imatinib in Patients With Chronic Myeloid Leukemia (CML), Resistant to Standard Dose Imatinib – a Swedish Model Application”. Acta Oncologica 49 (6):851-58. https://doi.org/10.3109/0284186X.2010.495132.